U.S. Health and Human Services Secretary Robert F. Kennedy, Jr. has renewed a 2017 public health emergency declaration regarding opioid abuse, giving the HHS flexibility to ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Lawmakers are hoping to expand and improve upon a 2015 law that offers grants to county jails treating inmates experiencing substance use disorders. Act 80 provides funding for the use of naltrexone, ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

Lawmakers are hoping to expand and improve upon a 2015 law that offers grants to county jails treating inmates experiencing ...

Published in JAMA Network Open, a new study found that less than half of Medicaid plans cover all four of the FDA-approved medications, which include acamprosate, disulfiram, and oral and injectable ...

It doesn't matter how full you are, you can always fit in a bite or two or three of pie and ice cream. Scientists say it has ...

SALT LAKE CITY, March 4, 2025 /PRNewswire/ -- Shed, a telehealth clinic specializing in weight loss, is excited to announce the launch of Low-Dose Naltrexone (LDN), an innovative, therapeutic ...

SALT LAKE CITY, March 4, 2025 /PRNewswire/ -- Shed, a telehealth clinic specializing in weight loss, is excited to announce the launch of Low-Dose Naltrexone (LDN), an innovative, therapeutic solution ...

Naloxone and naltrexone are opioid antagonists that block the effects of opioids and other street drugs. These drugs belong to the same class but have different FDA-approved uses. Naloxone is a ...